Rare CIDEC coding variants enriched in age-related macular degeneration patients with small low-luminance deficit cause lipid droplet and fat storage defects von Kim, Sehyun, Stockwell, Amy, Qin, Han, Gao, Simon S, Sagolla, Meredith, Stoilov, Ivaylo, Wuster, Arthur, Lai, Phillip, Yaspan, Brian L, Jeanne, Marion

Volltext

The Impact of Systemic Factors on Clinical Response to Ranibizumab for Diabetic Macular Edema von Singh, Rishi P., MD, Habbu, Karishma, BA, Ehlers, Justis P., MD, Lansang, M. Cecilia, MD, MPH, Hill, Lauren, MS, Stoilov, Ivaylo, MD

Volltext

Advances in the treatment of diabetic retinopathy von Singh, Rishi P., Elman, Michael J., Singh, Simran K., Fung, Anne E., Stoilov, Ivaylo

Volltext

Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials von Wykoff, Charles C., MD, PhD, Elman, Michael J., MD, Regillo, Carl D., MD, Ding, Beiying, PhD, Lu, Na, PhD, Stoilov, Ivaylo, MD

Volltext

Expression patterns of mouse and human CYP orthologs (families 1–4) during development and in different adult tissues von Choudhary, Dharamainder, Jansson, Ingela, Stoilov, Ivaylo, Sarfarazi, Mansoor, Schenkman, John B.

Volltext

Effect of less aggressive treatment on diabetic retinopathy severity scale scores: analyses of the RIDE and RISE open-label extension von Goldberg, Roger A, Hill, Lauren, Davis, Tatiana, Stoilov, Ivaylo

Volltext

Changes in Treatment-Naive Pigment Epithelial Detachments Associated With the Initial Anti–Vascular Endothelial Growth Factor Injection: A Post Hoc Analysis From the HARBOR Trial von Javaheri, Michael, Hill, Lauren, Ghanekar, Avanti, Stoilov, Ivaylo

Volltext

Molecular Genetics of Primary Congenital Glaucoma in Brazil von Stoilov, Ivaylo R, Costa, Vital P, Vasconcellos, Jose P. C, Melo, Monica B, Betinjane, Alberto J, Carani, Jose C. E, Oltrogge, Ernst V, Sarfarazi, Mansoor

Volltext

Anti-VEGF-resistant subretinal fluid is associated with better vision and reduced risk of macular atrophy von Zarbin, Marco A, Hill, Lauren, Maunz, Andreas, Gliem, Martin, Stoilov, Ivaylo

Volltext

Efficacy of Faricimab versus Aflibercept in Diabetic Macular Edema in the 20/50 or Worse Vision Subgroup in Phase III YOSEMITE and RHINE Trials von Zarbin, Marco, Tabano, David, Ahmed, Ayesha, Amador, Manuel, Ding, Allan, Holekamp, Nancy, Lu, Xiao-Yu, Stoilov, Ivaylo, Yang, Ming

Volltext

Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy von Wykoff, Charles C, Khurana, Rahul N, Nguyen, Quan Dong, Kelly, Scott P, Lum, Flora, Hall, Rebecca, Abbass, Ibrahim M, Abolian, Anna M, Stoilov, Ivaylo, To, Tu My, Garmo, Vincent

Volltext

Simulating an Anti–Vascular Endothelial Growth Factor Switch in Neovascular Age-Related Macular Degeneration von Zarbin, Marco, Tsuboi, Min, Hill, Lauren F., Stoilov, Ivaylo

Volltext

Simulating an Anti-Vascular Endothelial Growth Factor Switch in Neovascular Age-Related Macular Degeneration: A HARBOR Subanalysis von Zarbin, Marco, Tsuboi, Min, Hill, Lauren F, Stoilov, Ivaylo

Volltext

326-OR: Faricimab for Diabetic Macular Edema: A Novel Anti–Angiopoietin-2/Anti–Vascular Endothelial Growth Factor Bispecific Antibody in Clinical Trials von SHETH, VEERAL, SAHNI, JAYASHREE, STOILOV, IVAYLO, WILLIS, JEFFREY R., WEIKERT, ROBERT

Volltext

Predicting vision gains with anti-VEGF therapy in neovascular age-related macular degeneration patients by using low-luminance vision von Frenkel, Ronald E P, Shapiro, Howard, Stoilov, Ivaylo

Volltext

Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes von Agostini, Hansjürgen, Abreu, Francis, Baumal, Caroline R., Chang, Dolly S., G. Csaky, Karl, Demetriades, Anna M., Kodjikian, Laurent, Lim, Jennifer I., Margaron, Philippe, Monés, Jordi M., Peto, Tunde, Ricci, Federico, Rüth, Matthias, Singh, Rishi P., Stoilov, Ivaylo, Swaminathan, Balakumar, Willis, Jeffrey R., Westenskow, Peter D.

Volltext

Efficacy of Faricimab vs Aflibercept in Diabetic Macular Edema in the 20/50 or Worse Vision Subgroup in Phase 3 YOSEMITE/RHINE Trials von Zarbin, Marco, Tabano, David, Ahmed, Ayesha, Amador, Manuel, Ding, Allan, Holekamp, Nancy, Lu, Xiao-Yu, Stoilov, Ivaylo, Yang, Ming

Volltext

Aflibercept Does Not Suppress Angiopoietin-2 in Patients With nAMD or DME von Avery, Robert L, Csaky, Karl G, Westenskow, Peter, Stoilov, Ivaylo, Diack, Cheikh

Volltext

Baseline Diabetic Retinopathy Severity and Time to Diabetic Macular Edema Resolution with Ranibizumab Treatment von Talcott, Katherine E., Valentim, Carolina C.S., Hill, Lauren, Stoilov, Ivaylo, Singh, Rishi P.

Volltext

50-OR: Identifying Risk of Blindness in Patients with Diabetic Retinopathy von NGUYEN, QUAN DONG, HALL, REBECCA, KELLY, SCOTT P., LUM, FLORA, STOILOV, IVAYLO, ABBASS, IBRAHIM M., TO, TU MY, ABOLIAN, ANNA, GARMO, VINCENT

Volltext